Other Events ·
Arcadia Biosciences received a notice from Nasdaq on August 4, 2026, indicating non-compliance with the minimum bid…
RKDAArcadia Biosciences, Inc.
Arcadia Biosciences received a notice from Nasdaq on August 4, 2026, indicating non-compliance with the minimum bid price requirement due to its stock trading below $1.00 for 30 consecutive business days ending August 3, 2026. The company has an initial compliance period of 180 calendar days, until February 1, 2027, to restore the closing bid price to at least $1.00 for ten consecutive business days. Failure to comply may result in a second compliance period or delisting proceedings, with potential remedies including a reverse stock split. Arcadia Biosciences operates in the agricultural biotechnology industry, developing crop protection products and traits.